Latest News about ARGX
Recent news which mentions ARGX
Earnings Scheduled For February 29, 2024
February 29, 2024
From Benzinga
From InvestorPlace
New Hope For Patients With Chronic Autoimmune Conditions: Johnson & Johnson's Investigational Drug Meets Primary Goal In Two Studies
February 05, 2024
From Benzinga
Halozyme's Ambitious Five-Year Plan: Analysts Optimistic On Growth, Eyeing Market Expansion
January 18, 2024
From Benzinga
5 Biotech Stocks That Could Be Big Winners in 2024 and Beyond
January 15, 2024
From Motley Fool
Argenx's Autoimmune Trial Stumble: Analysts Cut Price Targets, Warn of Risky Outcomes
December 21, 2023
Tickers
ARGX
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 21, 2023
From Benzinga
From Benzinga
Why Steelcase Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
December 20, 2023
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 20, 2023
From Benzinga
Why Aclarion Shares Are Trading Higher By Around 53%; Here Are 20 Stocks Moving Premarket
December 20, 2023
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 20, 2023
From Benzinga
FedEx Posts Downbeat Earnings, Joins Steelcase, argenx And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
December 20, 2023
From Benzinga
Stifel Maintains Buy Rating for argenx: Here's What You Need To Know
December 18, 2023
Tickers
ARGX
From Benzinga
Morgan Stanley Maintains Overweight Rating for argenx: Here's What You Need To Know
November 30, 2023
Tickers
ARGX
From Benzinga
From Benzinga
Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
November 28, 2023
From Benzinga
These 2 Stocks Are Falling in a Fading Rally
November 28, 2023
From Motley Fool
Why SpringWorks Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
November 28, 2023
From Benzinga
From InvestorPlace
Zscaler Posts Q1 Results, Joins argenx, Cool Company And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
November 28, 2023
From Benzinga
Antibody Player Dianthus Therapeutics Has Potential Amid Active M&A Landscape in Complement-Focused Firms: Analyst
November 22, 2023
From Benzinga
$1000 Invested In argenx 5 Years Ago Would Be Worth This Much Today
November 15, 2023
Tickers
ARGX
From Benzinga
Tech Titans Rising: 7 Underrated Stocks Set for Explosive Growth
November 06, 2023
From InvestorPlace
$1000 Invested In This Stock 5 Years Ago Would Be Worth $5,000 Today
November 01, 2023
Tickers
ARGX
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.